Loading...
Roll out of intraveneous artesunate under named patient programmes in the Netherlands, Belgium and France
BACKGROUND: Intravenous (IV) artesunate is the treatment of choice for severe malaria. In Europe, this treatment is only available in a few countries via named patient programmes (NPPs). As a case study, the legal and organisational aspects and pharmacovigilance of these NPPs and possibilities for h...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3848968/ https://ncbi.nlm.nih.gov/pubmed/24063858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-8-150 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|